Impaired glymphatic function as a biomarker for subjective cognitive decline: An exploratory dual cohort study

Documenti analoghi

• Impaired glymphatic function exacerbates tau propagation and the effect of tau pathology on cognitive decline in Alzheimer's disease
  di: Ying Luan, et al.
  Pubblicazione: (2025)
• Plasma biomarkers as core mediators in functional network abnormalities: Evidence from a two‐cohort study
  di: Min Wei, et al.
  Pubblicazione: (2025)
• Temporo‐frontoparietal hypoconnectivity as a biomarker for isolated language impairment in mild cognitive impairment: A cross‐cohort comparison
  di: Lin Huang, et al.
  Pubblicazione: (2024)
• The association between measures of subjective cognitive decline and Alzheimer’s disease plasma biomarkers in cognitively normal individuals
  di: Mark A Bernard, et al.
  Pubblicazione: (2024)
• Association of neighborhood disadvantage with cognitive function and cortical disorganization in an unimpaired cohort: An exploratory study
  di: Apoorva Safai, et al.
  Pubblicazione: (2025)